Home › Allergan tells shareholders to reject Valeant deal
 

Keywords :   


Allergan tells shareholders to reject Valeant deal

2014-06-23 16:54:08| Biotech - Topix.net

Allergan, the maker of Botox, said Monday that Valeant Pharmaceuticals' hostile takeover bid for the company is "grossly inadequate" and that shareholders should reject it.

Tags: deal tells shareholders reject

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Millicom believes takeover offer by Atlas undervalues the company
04.07Passes selects Bitmovin Player and Analytics to empower creators
04.07German study shows high consumer interest in 5G broadcast
04.07Tropical Depression One-E Graphics
04.07Tropical Depression One-E Forecast Discussion Number 1
04.07Tropical Depression One-E Wind Speed Probabilities Number 1
04.07Tropical Depression One-E Public Advisory Number 1
04.07Summary for Tropical Depression One-E (EP1/EP012024)
More »